)
)
)
Synlico Inc.
Synlico is focused on discovering and developing innovative therapies by proving causality to make cellular processes explainable, predictable, and engineerable. We combine generative model with causal structure discovery & inference and employ our AI models on a carefully curated comprehensive patients’ single-cell transcriptomics database. Our proprietary AI models identify causal relations between genes and quantify effects of any gene interventions on downstream targets directly in patients. We are applying our platform for novel mechanism/target discovery and causality-aided drug development. Synlico is a Johnson & Johnson Innovation JLABS@South San Francisco resident company.
Address
South San FranciscoCalifornia
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)